↓ Skip to main content

Mass cytometric functional profiling of acute myeloid leukemia defines cell cycle and immunophenotypic properties that correlate with known responses to therapy.

Overview of attention for article published in Cancer Discovery, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mass cytometric functional profiling of acute myeloid leukemia defines cell cycle and immunophenotypic properties that correlate with known responses to therapy.
Published in
Cancer Discovery, June 2015
DOI 10.1158/2159-8290.cd-15-0298
Pubmed ID
Authors

Behbehani, Gregory K, Samusik, Nikolay, Bjornson, Zach B, Fantl, Wendy J, Medeiros, Bruno C, Nolan, Garry P, G. K. Behbehani, N. Samusik, Z. B. Bjornson, W. J. Fantl, B. C. Medeiros, G. P. Nolan

Abstract

Acute myeloid leukemia (AML) is characterized by a high relapse rate that has been attributed to the quiescence of leukemia stem cells (LSCs), which renders them resistant to chemotherapy. However, this hypothesis is largely supported by indirect evidence and fails to explain the large differences in relapse rates across AML subtypes. To address this, bone marrow aspirates from 41 AML patients and five healthy donors were analyzed by high-dimensional mass cytometry. All patients displayed immunophenotypic and intracellular signaling abnormalities within CD34+CD38low populations and several karyotype and genotype-specific surface marker patterns were identified. The immunophenotypic stem and early progenitor cell populations from patients with clinically favorable core-binding factor AML demonstrated a five-fold higher fraction of cells in S-phase compared to other AML samples. Conversely, LSCs in less clinically favorable FLT3-ITD AML exhibited dramatic reductions in S-phase fraction. Mass cytometry also allowed direct observation of the in vivo effects of cytotoxic chemotherapy.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
Korea, Republic of 2 3%
United Kingdom 1 1%
Unknown 66 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 33%
Student > Ph. D. Student 11 15%
Other 9 13%
Student > Master 7 10%
Student > Postgraduate 5 7%
Other 16 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 25 35%
Medicine and Dentistry 14 19%
Biochemistry, Genetics and Molecular Biology 11 15%
Immunology and Microbiology 7 10%
Unspecified 4 6%
Other 11 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2017.
All research outputs
#1,169,918
of 11,218,652 outputs
Outputs from Cancer Discovery
#290
of 1,764 outputs
Outputs of similar age
#35,157
of 234,597 outputs
Outputs of similar age from Cancer Discovery
#14
of 69 outputs
Altmetric has tracked 11,218,652 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,764 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 234,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.